Association of Beta-Blockers with Survival on Patients Presenting with ACS Treated with PCI: A Propensity Score Analysis from the BleeMACS Registry
-
Published:2018-04-24
Issue:4
Volume:18
Page:299-309
-
ISSN:1175-3277
-
Container-title:American Journal of Cardiovascular Drugs
-
language:en
-
Short-container-title:Am J Cardiovasc Drugs
Author:
D’Ascenzo Fabrizio, Celentani Dario, Brustio Alessandro, Grosso AlbertoORCID, Raposeiras-Roubín Sergio, Abu-Assi Emad, Henriques Jose Paulo Simao, Saucedo Jorge, González-Juanatey José Ramón, Wilton Stephen B., Kikkert Wouter J., Nuñez-Gil Iván, Ariza-Sole Albert, Song Xiantao, Alexopoulos Dimitrios, Liebetrau Christoph, Kawaji Tetsuma, Huczek Zenon, Nie Shao-Ping, Fujii Toshiharu, Correia Luis, Kawashiri Masa-aki, García-Acuña José María, Southern Danielle, Alfonso Emilio, Terol Belén, Garay Alberto, Zhang Dongfeng, Chen Yalei, Xanthopoulou Ioanna, Osman Neriman, Möllmann Helge, Shiomi Hiroki, Kowara Michal, Filipiak Krzysztof, Wang Xiao, Yan Yan, Fan Jing-Yao, Ikari Yuji, Nakahayshi Takuya, Sakata Kenji, Yamagishi Masakazu, Kalpak Oliver, Kedev Sasko, Moretti Claudio, D’Amico Maurizio, Gaita Fiorenzo
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine,General Medicine
Reference34 articles.
1. Iannaccone M, Quadri G, Taha S, Ascenzo F, Montefusco A, Omede P, Jang IK, Niccoli G, Souteyrand G, Yundai C, Toutouzas K, Benedetto S, Barbero U, Annone U, Lonni E, Imori Y, Biondi-Zoccai G, Templin C, Moretti C, Luscher TF, Gaita F. Prevalence and predictors of culprit plaque rupture at OCT in patients with coronary artery disease: a meta- analysis. Eur Heart J Cardiovasc Imaging. 2015;17:1128–37. 2. Task Force Members. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541–619. 3. Naito R, Miyauchi K, Konishi H, Tsuboi S, Ogita M, Dohi T, Kasai T, Tamura H, Okazaki S, Isoda K, Daida H. Gender difference in long-term clinical outcomes following percutaneous coronary intervention during 1984–2008. Atherosclerosis. 2016;247:105–10. 4. Moretti C, D’Ascenzo F, Omedè P, Sciuto F, Presutti DG, Di Cuia M, Colaci C, Giusto F, Ballocca F, Cerrato E, Colombo F, Gonella A, Giordana F, Longo G, Vilardi I, Bertaina M, Orlando A, Andrini R, Ferrando A, DiNicolantonio JJ, Zoccai GB, Sheiban I, Gaita F. Thirty-day readmission rates after PCI in a metropolitan center in Europe: incidence and impact on prognosis. J Cardiovasc Med (Hagerstown). 2015;16(3):238–45. 5. Yusuf SL, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. JAMA. 1988;260(14):2088–93.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|